CCMDD: Tenofovir & Lamivudine & Dolutegravir (TLD) - Patient Registration or Transition Standard Operating Procedure

CCMDD: Tenofovir & Lamivudine & Dolutegravir (TLD) - Patient Registration or Transition Standard Operating Procedure

Outlines the process for switching stable adult patients on ART from first line regimen TEE (Tenofovir +Emtricitabine + Efavirenz) to TLD (Tenofovir + Lamivudine + Dolutegravir) in the CCMDD programme and the process for registration of new patients into CCMDD with regards to TLD.

Person affected:

  • Health Facility staff
  • Authorised Prescribers
  • Patients
  • CCMDD service provider staff
Type
Standard Operating Procedure (SOP)
Topic
CCMDD
HIV/AIDS
Language
English
Publisher
National Department of Health
Year
2020